 - Evidence of hepatic disease indicated by one or more of the following: SGOT AST andor SGPT ALT greater than 5 times the upper limit of normal. Bilirubin greater than 2 times the upper limit of normal except for patients with known Gilberts syndrome or those receiving indinavir who may be enrolled if the serum bilirubin is less than or equal to 5 times the upper limit of normal. 